ALGS vs CSGP · rev $3.6M vs P/E 484, rev $2.74B
Aligos Therapeutics Inc (ALGS) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
ALGS currently screens at market cap $44.1M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the ALGS and CSGP stock pages for the full models.
Not investment advice.